Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1811

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 1811
---
 for their services as a director. See “—2024 Summary Compensation Table” for more
information about compensation to our NEOs for 2024 and 2023. The following table presents the total compensation for each person who
served as a non-employee director during 2024.

2024
Director Compensation Table 

    Name 
    Year  
    Fees Earned or Paid in Cash ($)  
    Stock Awards ($)  
    Option Awards ($)  
    Total ($) 
  
    Nicholas H. Hemmerly 
    2024  
    $49,000  
    $0  
    $0  
    $49,000 

    Julie Kampf 
    2024  
    $42,500  
    $0  
    $0  
    $42,500 

    Holger Weis 
    2024  
    $44,000  
    $0  
    $0  
    $44,000 

    Alison W. Brady 
    2024  
    $40,000  
    $0  
    $0  
    $40,000 

Director
Agreements

On
September 8, 2021, the Company entered into Independent Director Agreements with each of Allison Brady, Holger Weis, Julie Kampf and
Nick Hemmerly (each, a “Director”) relating to their service as independent directors of the Company.

114

Pursuant
to each of the agreements, the Director agreed to serve as an independent director of the Company and to perform the duties consistent
with such position. In addition, pursuant to their respective agreements, Ms. Brady agreed to serve as a member of the Compensation Committee
and Audit Committee; Mr. Weis agreed to serve as a member of the Nomination Committee and the Chairman of the Audit Committee; Ms. Kampf
agreed to serve as a member of the Compensation Committee and as Chairman of the Nomination Committee of the Board; and Mr. Hemmerly
agreed to serve as Chairman of the Compensation Committee as well as a member of the Audit Committee and Nominating Committee.

Each
of the Directors confirmed that the Director is independent (as such term has been construed under Delaware law with respect to directors
of Delaware corporations and the OTC Markets, the NASDAQ Stock Exchange and the New York Stock Exchange). Each Director also confirmed
that, to their knowledge,